FIRST SOLAR, INC. Q3 FY2026 earnings call

• Manufacturing Expansion & CURE Deployment: First Solar is executing a disciplined 'learning space' approach to deploy its Clean Energy Upgrade (CURE) technology. This began with the Perrysburg Series 6 conversion in Q1 2026 and will extend to the first Series 7 conversion at the India facility in Q1 2027. India serves as a low-earnings-impact environment to refine deployment before replicating across the U.S. fleet.
• Facility Updates: The South Carolina Series 6 finishing facility is launching in two phases; Phase 1 started in Q3 2026, and Phase 2 is expected in mid-2027. Total 2027 production is forecasted at 2.2–2.5 GW for South Carolina and 2.2–2.6 GW for India.
• Perovskite R&D: The Ohio pilot line for Series 6 size perovskite modules is on track for operational readiness in H1 2027. Licensing agreements with Cubic PV and Oxford PV support this roadmap.
• Strategic Positioning: Management views Section 232 tariffs as a structural shift benefiting First Solar due to its lack of dependency on Chinese crystalline silicon supply chains. By 2027, nearly 80% of global module manufacturing will be located in the U.S.
• Booking Strategy Shift: There is a deliberate shift from multi-year framework agreements to project-specific contracts with defined delivery schedules. This provides greater certainty and allows for optimized module allocation, though it has moderated recent booking volumes compared to historical framework additions.

The transcript does not break down financial performance by specific product segments (e.g., Series 6 vs. Series 7, or domestic vs. international). The company reports consolidated net sales of approximately $1.2 billion and an adjusted EBITDA of $744 million for the quarter.

• Full Year 2026 Revenue/EBITDA: Guidance was reduced to reflect the lower end of forecasts for India domestic/international Series 6 volume and U.S. finishing volume sold.
• India Volume: Full-year India domestic volume sold forecast reduced by approximately 0.7 gigawatts.
• U.S. Volume: The total U.S. component volume sold forecast range reflects a modest reduction based on reduced Series 6 WIP share product, but the forecast range for fully domestic product sold remains unchanged.
• Operating Expenses: Total 2026 operating expense guidance remains unchanged. Increases in legal spend (IP defense) and perovskite R&D (now ~$120 million, up from ~$100 million) were offset by delayed startup expenses at the South Carolina facility.
• Malaysia Facility Decision: A binary decision on the long-term operating path for the Malaysia facility (full capacity vs. shutdown) is expected in H1 2027.
• Net Cash: Guidance remains unchanged at maintaining a net cash balance within the $1.5–$2 billion target range.

• Regulatory & Tariff Uncertainty: Volatility in module procurement due to evolving Section 232 tariff landscape, potential minimum import prices (MIP), and incomplete final FIACT guidance.
• Project Delays: Increased NIMBYism, state/local government opposition, interconnection challenges, and surging battery prices are challenging near-term project economics and causing developers to defer early-stage procurement.
• Enforcement Challenges: Aggressive risk-taking by importers attempting to bypass tariffs via stockpiling or misclassification, despite Commerce Department enforcement efforts.
• Litigation: Potential liabilities related to the Swift Current lawsuit regarding initial Series 7 launch issues; management maintains it will stand behind warranty obligations but disputes remedies sought outside those parameters.
• Competition Risks: Competitors may not be truly 'free and unencumbered' from Chinese dependencies, creating perceived risks for customers, though some competitors face scrutiny regarding related-party transactions.

Q: Analysts noted a lack of urgency among developers to book 2029 volumes despite expected price increases. Why are customers delaying long-term commitments?

A: Mark Widmar explained that developers are prioritizing immediate execution hurdles, including securing financing, resolving interconnection challenges, and navigating local community opposition (NIMBYism). Additionally, customers are focused on meeting 2028 safe harbor requirements rather than planning further out. Alex Bradley added that the shift toward project-specific contracting reduces visibility into late-decade needs compared to framework agreements, contributing to the slower pace of bookings for 2029+ deliveries.

Q: How is pricing evolving post-Section 232 announcement, and what is the expected range for new deals?

A: Management stated that pricing is undergoing discovery and varies significantly by product type and origin. International modules (e.g., from Malaysia) sit at the lower end of the pricing continuum, while domestically manufactured Series 7 products command higher prices. Recent U.S. bookings averaged ~36 cents/watt, but this includes pre-232 negotiations. New opportunities initiated after the announcement have seen increased pricing, though exact future ranges depend on market clarity and competitor crystalline silicon pricing dynamics.

Q: What is the strategic rationale behind shifting from framework agreements to project-specific contracts?

A: Alex Bradley highlighted that framework agreements often led to significant volatility in delivery timing, forcing First Solar to hold excess inventory and incur higher working capital and storage costs. Project-specific contracts provide greater certainty on project permitting, financing, and interconnection status, allowing for more efficient operational planning, reduced inventory burdens, and improved financial efficiency, despite potentially moderating the speed of backlog accumulation.

Q: When will the decision on the Malaysia facility's future be made, and what factors influence it?

A: Management expects to make a binary decision on the Malaysia facility in H1 2027. The facility currently operates at low throughput to preserve optionality. The decision will depend on understanding customer demand for fully finished international modules post-Section 232, the flow of volume from India to the U.S., and the overall trade/tariff environment. If demand for international finished goods materializes, they may run at full capacity (128 GW); otherwise, production may cease.

Q: How does First Solar’s Series 7 technology compare competitively against PERC and TOPCon regarding energy profile and pricing?

A: Mark Widmar clarified that unlike crystalline silicon, which applies quality factors reducing energy predictions, First Solar’s technology is underwritten without such discounts. Series 7 CURE is advantaged against PERC technology due to better bifaciality and performance in hot/humid climates. However, it may be slightly disadvantaged against TOPCon by a few pennies depending on geography. Competition also hinges on whether rival U.S. manufacturers are truly free from Chinese supply chain dependencies, a key concern for many customers.